| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.
|
Bull World Health Organ
|
2008
|
8.70
|
|
2
|
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
|
J Natl Cancer Inst
|
2005
|
6.69
|
|
3
|
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
|
Lancet
|
2010
|
6.02
|
|
4
|
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.
|
Trop Med Int Health
|
2008
|
5.32
|
|
5
|
Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings.
|
Bull World Health Organ
|
2008
|
3.85
|
|
6
|
Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis.
|
Trop Med Int Health
|
2012
|
3.43
|
|
7
|
Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.
|
AIDS
|
2008
|
3.31
|
|
8
|
Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis.
|
AIDS
|
2012
|
3.05
|
|
9
|
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.
|
S Afr Med J
|
2009
|
2.97
|
|
10
|
Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.
|
Pharmacogenet Genomics
|
2005
|
2.94
|
|
11
|
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.
|
J Acquir Immune Defic Syndr
|
2014
|
2.79
|
|
12
|
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
|
AIDS
|
2009
|
2.75
|
|
13
|
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.
|
PLoS Med
|
2013
|
2.60
|
|
14
|
Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.
|
Clin Infect Dis
|
2007
|
2.51
|
|
15
|
Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.
|
J Acquir Immune Defic Syndr
|
2011
|
2.39
|
|
16
|
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
|
J Acquir Immune Defic Syndr
|
2010
|
2.21
|
|
17
|
Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa.
|
J Acquir Immune Defic Syndr
|
2012
|
2.03
|
|
18
|
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.
|
AIDS
|
2013
|
1.88
|
|
19
|
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.
|
J Infect Dis
|
2008
|
1.76
|
|
20
|
Outcomes of antiretroviral treatment programs in rural Southern Africa.
|
J Acquir Immune Defic Syndr
|
2012
|
1.60
|
|
21
|
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
|
Gut
|
2010
|
1.53
|
|
22
|
Mortality and loss to follow-up in the first year of ART: Malawi national ART programme.
|
AIDS
|
2012
|
1.50
|
|
23
|
Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.
|
J Acquir Immune Defic Syndr
|
2015
|
1.48
|
|
24
|
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
|
Am J Epidemiol
|
2013
|
1.48
|
|
25
|
Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.
|
PLoS One
|
2013
|
1.43
|
|
26
|
The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring.
|
AIDS
|
2012
|
1.32
|
|
27
|
Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
|
PLoS One
|
2013
|
1.32
|
|
28
|
Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis.
|
AIDS
|
2012
|
1.26
|
|
29
|
Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients.
|
J Hepatol
|
2005
|
1.17
|
|
30
|
Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review.
|
PLoS One
|
2013
|
1.15
|
|
31
|
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.
|
PLoS One
|
2011
|
1.15
|
|
32
|
Growth response to antiretroviral treatment in HIV-infected children: a cohort study from Lilongwe, Malawi.
|
Trop Med Int Health
|
2010
|
1.13
|
|
33
|
Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study.
|
PLoS One
|
2013
|
1.11
|
|
34
|
Variability of growth in children starting antiretroviral treatment in southern Africa.
|
Pediatrics
|
2012
|
1.08
|
|
35
|
Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.
|
Clin Infect Dis
|
2014
|
1.07
|
|
36
|
Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration.
|
Trop Med Int Health
|
2011
|
1.05
|
|
37
|
Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?
|
Am J Epidemiol
|
2014
|
0.98
|
|
38
|
Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies.
|
Afr J AIDS Res
|
2009
|
0.98
|
|
39
|
Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi.
|
J Acquir Immune Defic Syndr
|
2014
|
0.92
|
|
40
|
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2012
|
0.91
|
|
41
|
Outcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared.
|
J Int AIDS Soc
|
2013
|
0.91
|
|
42
|
Brief Report: HIV Testing Among Pregnant Women Who Attend Antenatal Care in Malawi.
|
J Acquir Immune Defic Syndr
|
2015
|
0.90
|
|
43
|
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
|
PLoS Med
|
2013
|
0.89
|
|
44
|
Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs.
|
Pediatr Infect Dis J
|
2014
|
0.88
|
|
45
|
Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.
|
Clin Infect Dis
|
2011
|
0.87
|
|
46
|
A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA.
|
PLoS One
|
2011
|
0.86
|
|
47
|
The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
|
Trop Med Int Health
|
2012
|
0.86
|
|
48
|
Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies.
|
J Acquir Immune Defic Syndr
|
2012
|
0.84
|
|
49
|
Social meets molecular: Combining phylogenetic and latent class analyses to understand HIV-1 transmission in Switzerland.
|
Am J Epidemiol
|
2014
|
0.83
|
|
50
|
Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003-2008.
|
J Perinat Med
|
2010
|
0.82
|
|
51
|
Impact of viral load and the duration of primary infection on HIV transmission: systematic review and meta-analysis.
|
AIDS
|
2014
|
0.82
|
|
52
|
Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.
|
Pediatr Infect Dis J
|
2015
|
0.81
|
|
53
|
Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
|
AIDS
|
2014
|
0.81
|
|
54
|
Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa.
|
AIDS
|
2013
|
0.80
|
|
55
|
Age-specific and sex-specific weight gain norms to monitor antiretroviral therapy in children in low-income and middle-income countries.
|
AIDS
|
2015
|
0.79
|
|
56
|
Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.
|
AIDS
|
2016
|
0.78
|
|
57
|
In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
|
Pediatr Infect Dis J
|
2016
|
0.75
|
|
58
|
Life expectancy trends in adults on antiretroviral treatment in South Africa.
|
AIDS
|
2016
|
0.75
|
|
59
|
Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSM.
|
AIDS
|
2017
|
0.75
|
|
60
|
Tenofovir-containing nucleoside/nucleotide-only antiretroviral maintenance therapy: decision making and virological outcome.
|
HIV Clin Trials
|
2006
|
0.75
|
|
61
|
Reporting of observational studies in Antiviral Therapy: a case for STROBE?
|
Antivir Ther
|
2008
|
0.75
|
|
62
|
Impact of screening and ART on anal cancer incidence in HIV-positive men who have sex with men: mathematical modeling study.
|
AIDS
|
2017
|
0.75
|